Purdue Scientists Join in Launch of Cloud-based Canine Cancer Database to Benefit Humans and Their Best Friends
Friday, September 11th, 2020 - The National Cancer Institute has announced the development of the Integrated Canine Data Commons (ICDC), which has significant ties to the Purdue University College of Veterinary Medicine. Developed by the Frederick National Laboratory for Cancer Research, the cloud-based repository of spontaneously arising canine cancer data was created with the goal of advancing human cancer research by enabling comparative analysis of canine cancer.
Foundations Unite to Support PVM Comparative Oncology Research
Friday, July 10th, 2020 - You can’t put a price on unconditional love and affection from a pet. But an avid animal-loving Indiana couple’s gratitude for the opportunity to spend more time with their beloved, cancer-stricken canine companion inspired a $1 million gift to support the Purdue Comparative Oncology Program (PCOP) that is part of the Purdue University College of Veterinary Medicine and an integral component of the Purdue University Center for Cancer Research (PCCR).
BMS Scholar Helps Lead Cancer Research Team Harnessing Protein Power to Stop Tumor Growth
Friday, April 10th, 2020 - Dr. Marxa Figueiredo, associate professor of basic medical sciences in the College of Veterinary Medicine, played a leadership role on a team of Purdue University scientists who have created a new therapy option that may help halt tumor growth in certain cancers such as prostate, which is among the most common types of cancer in men.
PVM Researcher Shares Insights about African Cancer Research on Global Cancer Information Website
Friday, February 21st, 2020 - The online platform ecancer, which seeks to raise the standards of care for cancer patients across the world through education, recently posted a video of an interview with Dr. Sulma Mohammed, professor of cancer biology in Purdue Veterinary Medicine’s Department of Comparative Pathobiology.
BMS Scholar Helps Lead Team Studying Worldwide Patented Innovations Available for Gene Therapy Treatment
Friday, February 14th, 2020 - The global gene therapy market is expected to reach $13 billion by 2024 as new treatment options target cancers and other diseases. Dr. Marxa Figueiredo, associate professor of basic medical sciences in the Purdue University College of Veterinary Medicine, has helped lead a team of scientists from Purdue and other research institutions around the world who came together to better understand the growing number of worldwide patented innovations available for gene therapy treatment.
Novel techniques for mining patented gene therapies offer promising treatment options for cancers, other diseases
Monday, February 10th, 2020 - The global gene therapy market is expected to reach $13 billion by 2024 as new treatment options target cancers and other diseases. Now, a team of scientists from Purdue University and other research institutions around the world have come together to better understand the growing number of worldwide patented innovations available for gene therapy treatment. They specifically focus on...
Comparative Blood-Brain Barrier Laboratory Seeks to Unlock Mystery of Lung Cancer Brain Metastases
Monday, December 16th, 2019 - The research team at the Comparative Blood-Brain Barrier Laboratory (CBBBL) in the Purdue University College of Veterinary Medicine is conducting studies that aim to improve drug delivery techniques, increase the lung cancer survival rate, and enhance quality of life for patients.
Cancer Research Breakthroughs
Monday, December 16th, 2019 - Although scientists know that the solution to preventing breast cancer won’t come easily, a team of researchers, including Dr. Sophie Lelièvre, professor of cancer pharmacology in Purdue Veterinary Medicine’s Basic Medical Sciences Department, has announced the recent discovery of one of the puzzle pieces to cancer prevention.
PVM Faculty Collaborate for Cancer Research
Monday, December 16th, 2019 - The Purdue Center for Cancer Research (PCCR) is honoring the legacy of Tyler Trent – the Purdue graduate and superfan who died January 1 at age 20 of the rare bone cancer osteosarcoma – through three new collaborative research initiatives, two of which involve Purdue’s College of Veterinary Medicine.